Include gradual dose reduction, continued dietary modifications, regular exercise, behavioral support, and potentially transitioning to alternative weight management strategies
If your syringe marks every 2 units, you need to estimate the midpoint between 36 and 38
The platform's structure is designed to ensure every appropriate candidate can access GLP-1 therapy through an administration route compatible with their life circumstances
The head-to-head SURMOUNT-5 data leaves no room for debate: tirzepatide outperforms semaglutide for weight loss in the same patient population
Real consultations, real oversight, real adjustments based on how you're responding
Ideal candidates often include those who have: Experienced limited success with diet and exercise alone